Generator-based PET radiopharmaceuticals for molecular imaging of tumours: on the way to THERANOSTICS
- 29 March 2011
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 40 (23) , 6104-6111
- https://doi.org/10.1039/c0dt01504k
Abstract
Generator-derived radionuclides for PET/CT imaging are promising for optimizing targeted radiotherapy by an individual patient-based approach, applying pre-therapeutic evaluation, as well as dosimetric calculations, and for measuring treatment response after radionuclide therapy.Keywords
This publication has 21 references indexed in Scilit:
- Post-elution processing of 44Ti/44Sc generator-derived 44Sc for clinical applicationApplied Radiation and Isotopes, 2010
- Molecular Imaging of HER2-Expressing Malignant Tumors in Breast Cancer Patients Using Synthetic 111In- or 68Ga-Labeled Affibody MoleculesJournal of Nuclear Medicine, 2010
- Results of Individual Patient Dosimetry in Peptide Receptor Radionuclide Therapy with 177Lu DOTA-TATE and 177Lu DOTA-NOCCancer Biotherapy & Radiopharmaceuticals, 2007
- Imaging of Neuroendocrine TumorsSeminars in Nuclear Medicine, 2006
- Production of positron-emitting 110mIn via the processApplied Radiation and Isotopes, 1997
- Radiochemistry of germaniumJournal of Radioanalytical and Nuclear Chemistry, 1996
- Radiation doses of yttrium-90 citrate and yttrium-90 EDTMP as determined via analogous yttrium-86 complexes and positron emission tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- A 62Zn/62Cu generator for the routine production of 62Cu-PTSMInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1992
- 62Cu-labeling of human serum albumin-dithiosemicarbazone(HSA-DTS) conjugate for regional plasma volume measurement: Application of new 62Zn/62Cu generator system.CHEMICAL & PHARMACEUTICAL BULLETIN, 1990
- Production of high specific activity 117mSn with the szilard‐chalmers processJournal of Labelled Compounds and Radiopharmaceuticals, 1989